Sandoz to Acquire CIMERLI from Coherus for $170 Million
CRISPR Regulatory Updates
Biosimilar Deals Updates: Biocon, AstraZeneca
European Biologics Regulatory Updates
Recent Adalimumab Biosimilar Developments
Bristol-Myers Squibb and AstraZeneca Settle Anti-PD-L1 Antibody Product Litigation
FDA Approves the Cyltezo Pen, an autoinjector option for Adalimumab
FDA Guidance on Continuous Manufacturing of Drug Substances and Drug Products
Samsung Bioepis Announces Approval of Citrate-Free, High-Concentration Adalimumab Biosimilar in Canada
Subscribe: Subscribe via RSS
Blogs
Firm/Org